the urge to merge in the pharmaceutical industry
By: HERACLEOUS, Loizos
.
Contributor(s): MURRAY,John.
Material type: 
ArticlePublisher: 2001Subject(s): Glaxo SmithKline | Mergers | Pharmaceutical Industry | Shareholder ValueEuropean Management Journal 19, 4, p. 430-437Abstract: This Case Study focuses on the giant GlaxoWellcome and SmithKline Beecham merger to form of evidence to show that mergers frequently destroy shareholder values. The pharmaceutical sector is no exception, even through companies are in the early stages of healthy growth and not seeking consolidation because they are mature. The urge to merge is stimulated essentially by intense competitive pressures in pharmaceuticals. Chief Executive Jean Pierre Garnier faced many challenges in early 2000, primarily how to deliver the promise of the merger. Teh case study analyses the growth of the pharmaceutical industry, its business system and value chain, ad the steps to merge between Glaxo Wellcome and SmithKilne Beecham. Teh case is followed by commentaries from experts in the field which help to form opinion on whether the merger will succed
| Item type | Current location | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Periódico | Biblioteca Graciliano Ramos | Periódico | Not for loan |
This Case Study focuses on the giant GlaxoWellcome and SmithKline Beecham merger to form of evidence to show that mergers frequently destroy shareholder values. The pharmaceutical sector is no exception, even through companies are in the early stages of healthy growth and not seeking consolidation because they are mature. The urge to merge is stimulated essentially by intense competitive pressures in pharmaceuticals. Chief Executive Jean Pierre Garnier faced many challenges in early 2000, primarily how to deliver the promise of the merger. Teh case study analyses the growth of the pharmaceutical industry, its business system and value chain, ad the steps to merge between Glaxo Wellcome and SmithKilne Beecham. Teh case is followed by commentaries from experts in the field which help to form opinion on whether the merger will succed
Click on an image to view it in the image viewer
There are no comments for this item.